Endoworm: A new semi-autonomous enteroscopy device

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Sanchez-Diaz, C
- Senent-Cardona, E
- Santonja-Gimeno, A
- Vidaurre, A
Grupos
Abstract
Using enteroscopes with therapeutic capacity to explore the small intestine entails certain limitations, including long exploration times, patient discomfort, the need for sedation, a high percentage of incomplete explorations and a long learning curve. This article describes the advances and setbacks encountered in designing the new Endoworm enteroscopy system, a semi-autonomous device consisting of a control unit and three cavities that inflate and deflate in such a way that the bowel retracts over the endoscope. The system can be adapted to any commercial enteroscope. Endoworm was tested in different intestine models: a polymethyl methacrylate rigid tube, an in vitro polyester urethane model, an ex vivo pig model and an in vivo animal model. The general behavior of the prototype was evaluated by experienced medical personnel. The mean distance covered through the lumen was measured in each cycle. The system was found to have excellent performance in the rigid tube and in the in vitro model. The ex vivo tests showed that the behavior depended largely on the mechanical properties of the lumen, while the in vivo experiments suggest that the device will require further modifications to improve its performance.
Datos de la publicación
- ISSN/ISSNe:
- 0954-4119, 2041-3033
- Tipo:
- Article
- Páginas:
- 1137-1143
- Factor de Impacto:
- 0,455 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE SAGE PUBLICATIONS LTD
Citas Recibidas en Web of Science: 3
Documentos
- No hay documentos
Filiaciones
Keywords
- Endoscopy; gastroenterology; medical control systems; medical diagnosis
Proyectos asociados
RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010
WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.
Investigador Principal: VICENTE PONS BELTRÁN
675353 . COMISION EUROPEA . 2016
ESTUDIO DE FASE III, ALEATORIZADO, A DOBLE CIEGO, CONTROLADO CON PLACEBO SOBRE TERAPIA ADYUVANTE CON VEMURAFENIB (RO5185426) EN PACIENTES CON MELANOMA CUTÁNEO CON MUTACIÓN DE BRAF RESECADO QUIRÚRGICAMENTE CON ALTO RIESGO DE RECIDIVA.
Investigador Principal: ROBERTO PEDRO DÍAZ BEVERIDGE
GO27826 . 2013
ESTUDIO ALEATORIZADO Y ABIERTO, PARA COMPARAR DURANTE 26 SEMANAS EL EFECTO DEL TRATAMIENTO CON GEL INTESTINAL DE LEVODOPA-CARBIDOPA (GILC) Y DEL TRATAMIENTO MÉDICO ÓPTIMO (TMO) SOBRE LOS SÍNTOMAS NO MOTORES (SNM) EN PACIENTES CON ENFERMEDAD DE PARKINSON AVANZADA - ESTUDIO INSIGHTS.
Investigador Principal: IRENE MARTÍNEZ TORRES
M12-927 . 2015
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENTYVIO (VEDOLIZUMAB IV) IN THE TREATMENT OF CHRONIC POUCHITIS./ ESTUDIO DE FASE IV ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE ENTYVIO (VEDOLIZUMAB I.V.) EN EL TRATAMIENTO DE LA POUCHITIS CRÓNICA.
Investigador Principal: GUILLERMO BASTIDA PAZ
VEDOLIZUMAB-4004 . 2017
Cita
Sanchez C,Senent E,Pons V,Santonja A,Vidaurre A. Endoworm: A new semi-autonomous enteroscopy device. Proc. Inst. Mech. Eng. Part H-J. Eng. Med. 2018. 232. (11):p. 1137-1143. IF:1,317. (4).